MEMY yields 3.78% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MEMY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MEMY + PFE for your $10,000?
MEMY is an actively managed ETF that seeks current income by investing in meme stocks with an options overlay strategy. Meme stocks gain rapid popularity on social media and are highly volatile and speculative, often trading above fundamental valuations. The fund identifies investments by monitoring social media for unusual discussion volume, trending topics, and strong sentiment, along with quantitative metrics. It selects 1530 US-listed stocks or ETPs with high implied volatility, from any market cap or sector. MEMY combines direct stock holdings with synthetic exposures, using options such as buying calls and selling puts at similar strikes, including deep in-the-money calls. To generate income and manage risk, the fund employs systematic put credit spreads, choosing options based on volatility, expiration, and overall market conditions. Positions are actively adjusted based on options market signals and shifting social sentiment flows, with spreads rolled regularly.
Full MEMY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.